Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Micro Focus InternationalGB GroupAurinia PharmaceuticalsTecsysIdeagen
SymbolLON:MCROLON:GBGTSE:AUPTSE:TCSLON:IDEA
Price Information
Current PriceGBX 550GBX 900C$15.75C$44.65GBX 295
52 Week RangeHoldHoldHoldBuyBuy
MarketRank™
Overall Score1.01.20.91.20.8
Analysis Score1.01.10.02.51.5
Community Score2.73.42.82.71.7
Dividend Score0.80.00.00.80.8
Ownership Score0.01.71.70.00.0
Earnings & Valuation Score0.60.00.00.00.0
Analyst Ratings
Consensus RecommendationHoldHoldHoldBuyBuy
Consensus Price TargetGBX 384.17GBX 711.50N/AC$53.00GBX 310
% Upside from Price Target-30.15% downside-20.94% downsideN/A18.70% upside5.08% upside
Trade Information
Market Cap£1.84 billion£1.77 billionC$2.01 billionC$645.86 million£744.27 million
BetaN/AN/AN/AN/AN/A
Average Volume1,781,947304,918175,96333,912652,068
Sales & Book Value
Annual Revenue£3.00 billion£208.31 millionC$50.12 millionC$118.02 million£58.42 million
Price / Sales0.618.4840.055.4712.74
CashflowGBX 218.83 per shareGBX 16.39 per shareC$3.07 per shareC$2.47 per shareGBX 5.21 per share
Price / Cash2.5154.915.1318.0956.60
Book ValueGBX 960 per shareGBX 184.50 per shareC$3.22 per shareC$4.57 per shareGBX 34.60 per share
Price / Book0.010.054.899.770.09
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (884.60)GBX 11.80C($1.09)C$0.39GBX 0.20
Trailing P/E RatioN/A76.27N/A115.371,475.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AC$0.25GBX 0
Dividend YieldN/AN/AN/A0.55%0.00%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A63.31%1.60%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio154.54%11.04%2.06%29.27%61.86%
Current Ratio0.86%1.06%13.11%1.73%0.41%
Quick Ratio0.82%1.06%12.48%1.58%0.41%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees11,9001,000294514576
Shares Outstanding335.40 million196.30 million127.45 million14.47 million252.30 million
Next Earnings Date7/5/2021 (Estimated)6/28/2021 (Estimated)5/13/2021 (Estimated)7/14/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Ideagen (LON:IDEA) Share Price Crosses Above Fifty Day Moving Average of $277.89Ideagen (LON:IDEA) Share Price Crosses Above Fifty Day Moving Average of $277.89
americanbankingnews.com - April 6 at 2:38 AM
Investors Who Bought Ideagen (LON:IDEA) Shares Five Years Ago Are Now Up 464%Investors Who Bought Ideagen (LON:IDEA) Shares Five Years Ago Are Now Up 464%
finance.yahoo.com - April 4 at 9:36 AM
Ideagen (LON:IDEA) Stock Crosses Below 50 Day Moving Average of $280.72Ideagen (LON:IDEA) Stock Crosses Below 50 Day Moving Average of $280.72
americanbankingnews.com - March 27 at 2:54 AM
SIPCHEM Demonstrates Commitment and Sustainable Progression to Quality with Q-PulseSIPCHEM Demonstrates Commitment and Sustainable Progression to Quality with Q-Pulse
wboc.com - March 23 at 1:19 PM
Ideagen PLC - Issue of new shares under the SIP and TVRIdeagen PLC - Issue of new shares under the SIP and TVR
proactiveinvestors.co.uk - March 16 at 1:51 PM
Software company to bring dozens of jobs to BlacksburgSoftware company to bring dozens of jobs to Blacksburg
msn.com - March 12 at 12:04 PM
Ideagen PLC - Acquisition of QualtraxIdeagen PLC - Acquisition of Qualtrax
proactiveinvestors.co.uk - March 9 at 10:08 PM
Ideagen acquires Blacksburgs QualtraxIdeagen acquires Blacksburg's Qualtrax
roanoke.com - March 9 at 5:07 PM
U.K. software company acquires Blacksburg firmU.K. software company acquires Blacksburg firm
virginiabusiness.com - March 9 at 12:07 PM
Ideagen acquires US firmIdeagen acquires US firm
insidermedia.com - March 9 at 12:07 PM
Software firm reveals new US headquarters after £10.75m acquisitionSoftware firm reveals new US headquarters after £10.75m acquisition
thebusinessdesk.com - March 9 at 7:06 AM
Ideagen acquires Qualtrax for $14.9mIdeagen acquires Qualtrax for $14.9m
stockmarketwire.com - March 9 at 7:06 AM
Ideagen buys compliance software firm Qualtrax in $14.9m dealIdeagen buys compliance software firm Qualtrax in $14.9m deal
hl.co.uk - March 9 at 7:06 AM
Ideagen Strengthens Presence in the Global Assurance Sector with the Acquisition of QualtraxIdeagen Strengthens Presence in the Global Assurance Sector with the Acquisition of Qualtrax
wicz.com - March 9 at 7:06 AM
Ideagen PLC - PDMR Dealing and Total Voting RightsIdeagen PLC - PDMR Dealing and Total Voting Rights
proactiveinvestors.co.uk - February 23 at 7:29 AM
Ideagen PLC - Director/PDMR DealingsIdeagen PLC - Director/PDMR Dealings
proactiveinvestors.co.uk - February 12 at 7:29 AM
H1 Results PresentationH1 Results Presentation
sharesmagazine.co.uk - February 7 at 7:28 AM
Ideagen PLC - Extension to 2018 LTIP AwardsIdeagen PLC - Extension to 2018 LTIP Awards
proactiveinvestors.co.uk - February 5 at 12:47 AM
Ideagen PLC - Unaudited Interim ResultsIdeagen PLC - Unaudited Interim Results
proactiveinvestors.co.uk - January 29 at 10:23 PM
Ideagen PLC - Issue of Equity & Total Voting RightsIdeagen PLC - Issue of Equity & Total Voting Rights
proactiveinvestors.co.uk - January 14 at 8:33 PM
What Type Of Shareholders Own The Most Number of Ideagen plc (LON:IDEA) Shares?What Type Of Shareholders Own The Most Number of Ideagen plc (LON:IDEA) Shares?
finance.yahoo.com - January 3 at 7:59 AM
Ideagen PLC - Completion of Huddle AcquisitionIdeagen PLC - Completion of Huddle Acquisition
proactiveinvestors.co.uk - December 31 at 11:38 PM
Ideagen PLC - Acquisition of HuddleIdeagen PLC - Acquisition of Huddle
proactiveinvestors.co.uk - December 25 at 9:00 PM
Ideagen PLC - Issue of Equity, PDMR Dealing and TVRIdeagen PLC - Issue of Equity, PDMR Dealing and TVR
proactiveinvestors.co.uk - November 22 at 1:09 AM
Ideagen PLC - PDMR Shareholding and Exercise of OptionsIdeagen PLC - PDMR Shareholding and Exercise of Options
proactiveinvestors.co.uk - November 7 at 1:48 PM
DateCompanyBrokerageAction
2/11/2021Micro Focus InternationalCredit Suisse GroupLower Price Target
2/10/2021Micro Focus InternationalBarclaysReiterated Rating
1/14/2021Micro Focus InternationalJPMorgan Chase & Co.Boost Price Target
7/27/2020Micro Focus InternationalUBS GroupLower Price Target
7/17/2020Micro Focus InternationalThe Goldman Sachs GroupReiterated Rating
7/8/2020Micro Focus InternationalJefferies Financial GroupLower Price Target
4/7/2020Micro Focus InternationalInvestecDowngrade
2/24/2020Micro Focus InternationalCitigroupLower Price Target
7/8/2020GB GroupBerenberg BankBoost Price Target
6/29/2020GB GroupPeel HuntReiterated Rating
10/24/2019GB GroupPeel HuntReiterated Rating
6/6/2019GB GroupNumis SecuritiesDowngrade
11/3/2020Aurinia PharmaceuticalsBloom BurtonDowngrade
10/17/2019Aurinia PharmaceuticalsCantor FitzgeraldReiterated Rating
3/19/2019Aurinia PharmaceuticalsSVB LeerinkReiterated Rating
2/26/2021TecsysLaurentianBoost Price Target
2/25/2021TecsysRaymond JamesReiterated Rating
12/4/2020TecsysLaurentian Bank of CanadaBoost Price Target
9/11/2020TecsysCormarkBoost Price Target
12/16/2019TecsysNational Bank FinancialSet Price Target
12/6/2019TecsysHaywood SecuritiesBoost Price Target
2/1/2019TecsysEchelon Wealth PartnersReiterated Rating
2/1/2019TecsysBeacon SecuritiesUpgrade
3/11/2021IdeagenShore CapitalReiterated Rating
3/9/2021IdeagenCanaccord GenuityReiterated Rating
5/19/2020IdeagenFinnCapReiterated Rating
(Data available from 4/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.